Greatbatch, Inc. (NYSE:GB) Q3 2016 Earnings Conference Call - Final Transcript
Oct 27, 2016 • 05:00 pm ET
to other integer locations in the United States. The project is expected to take 12 to 18 months, and will generate estimated annual synergies of about $4 million starting in 2018.
Let me conclude by reiterating what I said at the beginning of the call. Integer is a company that is well positioned within the medical technology market. And it is up to us to capitalize on the opportunities in front of us. We have expanded our medical device capabilities, and are excited about the opportunities to partner with our customers to drive innovation. We have the scale and global presence, supported by world-class manufacturing and quality capabilities.
We are confident in our abilities as one of the largest outsource medical device manufacturers, with a long history of successfully integrating companies, driving costs down, and growing revenues over the longer term. We will continue to create shareholder value by enhancing the lives of patients worldwide by being our customers' partner of choice for innovative medical technologies and services.
Operator, we will now turn to the question-and-answer portion of the call.